Ejection fraction (EF) measures the amount of blood pumped out of your heart's lower chambers, or ventricles. It's the percentage of blood that leaves your ventricle when your heart contracts. The ...

Ejection fraction refers to how much blood the heart pumps out during a contraction. An abnormal ejection fraction can be a sign of heart failure. Some people might need treatment to improve their ...

A once-daily polypill containing 3 guideline-directed therapies for heart failure with reduced ejection fraction (HFrEF) led ...

The role of ACE inhibitors in the management of HFPEF is less significant compared with their role in the management of heart failure with left ventricular systolic dysfunction. For patients with ...

An analysis of more than 12,000 patients has found that the SGLT2 inhibitors dapagliflozin and empagliflozin reduce cardiovascular death or hospitalization for heart failure by 20% in heart failure ...

Obesity and type 2 diabetes are prevalent in patients with heart failure with preserved ejection fraction and are characterized by a high symptom burden. No approved therapies specifically target ...

Chronic heart failure is a syndrome, not a specific disease, and occurs as a final common pathway in multiple disease states. The pathophysiology of chronic heart failure (HF) exists when either the ...

Compared with conventional rate or rhythm control, pulmonary vein isolation (PVI)-based catheter ablation was associated with reduced risk of HF events in HF with reduced ejection fraction, or HFrEF ...

Bayer expands indication of Kerendia in India to include heart failure with preserved and mildly reduced ejection fraction: Our Bureau, Bengaluru Thursday, November 6, 2025, 17:35 ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.